CGM approved by FDA for adults with diabetes; U.S. launch set for late 2025 with extended wear and advanced tracking features ...

Dexcom (Nadsaq:DXCM) announced today that the FDA cleared its G7 15-day continuous glucose monitoring (CGM) system.

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

In a first, the direct-to-watch feature gives Dexcom users of continuous glucose monitors information and alerts without being in range of their phone. It first rolled out in Ireland and the UK ...

The Apple Watch integration with the Dexcom G7 continuous glucose monitor (CGM) has revolutionized how people with diabetes monitor their glucose levels. Users can now view real-time blood sugar ...

such as Dexcom G7 and Dexcom G6, are equipped with a predictive Urgent Low Soon alert that can warn users up to 20 minutes in advance of a severe hypoglycemic event (< 3.1 mmol/L), prompting the ...